7 min read
Lymphoma Brother's Bone Marrow Bone Marrow Transplant Death Over-Treatment Lack of Informed Consent Outcome Misrepresentation Financial Exploitation Communication Breakdown Lack of AccountabilityThe patient received a bone marrow transplant using marrow from her brother. Rejection reactions developed after the transplant. She was readmitted to the hospital and died in the ward shortly afterward.
Death after bone marrow transplant.
When it comes to bone marrow transplantation, ordinary people need to focus on one essential detail: the HLA matching report. If a full 10/10 match has not been achieved, there is no need to proceed with the high costs of transplantation. It is that straightforward. The likelihood of a successful bone marrow transplant depends on whether a 10/10 HLA match is obtained. This has nothing to do with whether the donor is a blood relative. Let me repeat: bone marrow transplantation success is unrelated to blood relationship. If anyone wants to quibble with this statement, direct your criticism at me. Do not use the banner of family ties to lead ordinary families into confusion and unnecessary financial and emotional loss.
Had the family contacted this service at the same time they were seeking care, it would have been possible to avoid the complete loss of both life and savings.
We are not physicians operating a clinic. We hold no active medical licenses and have no authority to diagnose conditions, prescribe medications, administer treatments, or deliver personalized medical advice. Nothing published on this site, in any associated materials, or in direct communications from us should be interpreted as medical advice. If you are currently experiencing symptoms or health concerns, seek professional care at a hospital or from a licensed physician without delay.
All content we present may contain inaccuracies or oversights. We are human, and while we work diligently to maintain accuracy, errors can and do occur. Although members of our team have completed medical school, we do not engage in clinical practice. Our approach is grounded in the principle of free speech: we believe we have the right to discuss real treatment cases openly and transparently.
This matters profoundly. For the first time, ordinary people can access unfiltered accounts directly from patients describing what treatments succeeded or failed — without a physician standing between the patient and the audience to frame, narrate, or interpret every detail. It is the difference between letting individuals speak for themselves and always requiring someone else to speak on their behalf or remain present to "explain" their words. Allowing patients to share their own medical records represents a genuinely new form of transparency. The limitation, of course, is that patients are not trained medical writers; their raw stories can sometimes appear disorganized or invite criticism. Our limited role is simply to help organize and present that information clearly, without injecting clinical judgment or altering the underlying facts.
Today, only licensed doctors and medical institutions are generally permitted to publish, narrate, comment on, or pass judgment on treatment cases. This creates an exclusive system in which only insiders control the narrative. It is comparable to insisting that only the restaurant owner may publicly discuss the quality of their own establishment — while simultaneously allowing only a professional "restaurant guild" to review any restaurant at all. Patients and their families are effectively sidelined from the conversation about their own experiences.
That is how the current system operates. We are here to change it.